South Korea Poultry Vaccines Market Size, Share, and COVID-19 Impact Analysis, By Vaccine Type (Attenuated /Live Vaccines and Inactivated Vaccines), By Application (breeder and Layer), By Disease Type (Salmonella Disease and Avian Influenza), and South Korea Poultry Vaccines Market Industry Trend, Forecasts to 2035

South Korea Poultry Vaccines Market Insights Forecasts to 2035

• The South Korea Poultry Vaccines Market Size Was Estimated at USD 20.34 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 9.8% from 2025 to 2035
• The South Korea Poultry Vaccines Market Size is Expected to Reach USD 56.86 Million by 2035

According to a research report published by Spherical Insights & Consulting, The South Korea Poultry Vaccines Market Size is anticipated to reach USD 56.86 Million by 2035, growing at a CAGR of 9.8% from 2025 to 2035. Growing disease incidence, advancements in vectored and combination vaccines, and government financing for extensive vaccination campaigns and innovative initiatives are the main factors propelling the market.

Market Overview

The poultry vaccines market involves the development and use of vaccines to prevent infectious diseases in poultry, such as avian influenza, Newcastle disease, and salmonella. These vaccines help improve flock immunity, reduce mortality, enhance productivity, and ensure food safety. Benefits include lower antibiotic use, improved animal welfare, and better economic returns for farmers. The rising reginal poultry consumption, demand for disease-free meat and eggs, and innovations in vaccine delivery methods. Government initiatives, including mass vaccination programs, disease surveillance, and support for biosecurity measures, further boost market growth. In countries like South Korea, regulatory frameworks and public-private partnerships encourage vaccination to prevent zoonotic outbreaks, improve food exports, and maintain public health, creating a favorable environment for continued market expansion.

Report Coverage

This research report categorizes the market for South Korea poultry vaccines market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea poultry vaccines market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea poultry vaccines market.

Driving Factors

Rising concerns over zoonotic diseases and food safety push farmers and governments to adopt vaccination programs. Additionally, growing antibiotic resistance encourages vaccine use as a preventive alternative. Technological advancements in vaccine development and delivery, along with government support for disease control and biosecurity, further propel market growth. Expanding poultry farming in emerging economies also contributes significantly to rising demand.

Restraining Factors

High development and production costs, limiting affordability for small-scale farmers. Cold chain requirements and storage challenges affect vaccine efficacy, especially in remote areas. Limited awareness and inadequate veterinary infrastructure in some regions hinder widespread adoption. Additionally, the emergence of new or mutated disease strains can reduce vaccine effectiveness. Regulatory hurdles and stringent approval processes also slow market entry for new vaccines, while occasional vaccine side effects raise concerns among producers, restraining overall market growth.

Market Segmentation

The South Korea poultry vaccines market share is classified into vaccine type, application, and disease type.

• The attenuated /live vaccines segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea poultry vaccines market is segmented by vaccine type into attenuated /live vaccines and inactivated vaccines. Among these, the attenuated /live vaccines segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. Their high efficacy in inducing strong and long-lasting immune responses. These vaccines are particularly effective against viral diseases like Newcastle disease and infectious bronchitis, which are prevalent in poultry. Their ability to provide rapid protection and ease of mass administration, especially via drinking water or spray, supports widespread adoption. Increasing poultry production and focus on disease prevention further drive growth in this segment.

• The breeder segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea poultry vaccines market is segmented by application into breeder and layer. Among these, the breeder segment dominated a share in 2024 and is expected to grow at a significant CAGR during the forecast period. The critical role breeders play in maintaining flock health and productivity. Vaccinating breeders ensures maternal antibody transfer to chicks, offering early-life protection against diseases. Given their higher economic value, breeders receive comprehensive vaccination protocols to prevent disease outbreaks. The increasing demand for disease-free hatchlings and high-quality poultry products, along with a focus on improving flock genetics and biosecurity, is driving consistent growth in this segment through the forecast period.

• The salmonella disease segment dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea poultry vaccines market is segmented by disease type into salmonella disease and avian influenza. Among these, the salmonella disease segment dominated share in 2024 and is expected to grow at a significant CAGR during the forecast period. The growing concerns over food safety and zoonotic transmission. Salmonella poses a major public health risk through contaminated poultry products, prompting stringent government regulations and mandatory vaccination programs. Poultry producers increasingly adopt salmonella vaccines to reduce infection rates, enhance product safety, and meet export standards.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea poultry vaccines market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• KOMIPHARM INTERNATIONAL CO., LTD.
• CHOONGANG VACCINE LAB INC. (CAVAC)
• KBNP INC.
• SK Bioscience Co., Ltd.
• Yuhan Corporation
• GC Biopharma (Green Cross Corporation)
• Chong Kun Dang
• Samsung Biologics Co., Ltd.
• Celltrion, Inc.
• Vetoquinol
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea poultry vaccines market based on the below-mentioned segments:

South Korea Poultry Vaccines Market, By Vaccine Type

• Attenuated /Live Vaccines
• Inactivated Vaccines

South Korea Poultry Vaccines Market, By Application

• Breeder
• Layer

South Korea Poultry Vaccines Market, By Disease Type

• Salmonella Disease
• Avian Influenza